BACKGROUND: Gamma knife radiosurgery (GKRS) is an established treatment for trigeminal neuralgia. Identifying factors that influence outcome will help improve patients' results. METHODS: We conducted a retrospective review of all patients treated with GKRS for trigeminal neuralgia at our institution from 2005 to 2010. Patients' clinical features and treatment details were reviewed. Analysis was performed to identify predictors of response and recurrence. RESULTS: A hundred and forty five patients were treated. Mean follow up period was 24 months. At last follow up, 48 patients (33%) were pain free with no medications, and 48 patients (33%) were pain free maintained on medications. Twenty-eight patients (19%) had pain after the treatment but had significant reduction in their pain severity. Twenty-one patients (15%) did not have any significant pain reduction. Forty-four patients (30%) developed facial numbness. Recurrence occurred in 51 patients (35%). Post-treatment numbness was a predictor of good treatment response (OR 2.720, CI 1.193-6.200, p 0.0173). Higher integrated dose was a predictor of poor pain response to radiosurgery (OR 0.729, CI 0.566-0.940, p 0.0146). At an integrated dose value of 5.3 mJ or less, there was more than 50% chance of pain free outcome. Longer pain duration prior to treatment was the only independent predictor of increased recurrence risk (HR 1.038, 95%CI 1.001-1.075; p=0.0412). CONCLUSIONS: Radiosurgery is an effective treatment modality for trigeminal neuralgia. Post treatment numbness is associated with good treatment response and higher integrated dose predicts poor outcome after radiosurgery for trigeminal neuralgia.
BACKGROUND: Gamma knife radiosurgery (GKRS) is an established treatment for trigeminal neuralgia. Identifying factors that influence outcome will help improve patients' results. METHODS: We conducted a retrospective review of all patients treated with GKRS for trigeminal neuralgia at our institution from 2005 to 2010. Patients' clinical features and treatment details were reviewed. Analysis was performed to identify predictors of response and recurrence. RESULTS: A hundred and forty five patients were treated. Mean follow up period was 24 months. At last follow up, 48 patients (33%) were pain free with no medications, and 48 patients (33%) were pain free maintained on medications. Twenty-eight patients (19%) had pain after the treatment but had significant reduction in their pain severity. Twenty-one patients (15%) did not have any significant pain reduction. Forty-four patients (30%) developed facial numbness. Recurrence occurred in 51 patients (35%). Post-treatment numbness was a predictor of good treatment response (OR 2.720, CI 1.193-6.200, p 0.0173). Higher integrated dose was a predictor of poor pain response to radiosurgery (OR 0.729, CI 0.566-0.940, p 0.0146). At an integrated dose value of 5.3 mJ or less, there was more than 50% chance of pain free outcome. Longer pain duration prior to treatment was the only independent predictor of increased recurrence risk (HR 1.038, 95%CI 1.001-1.075; p=0.0412). CONCLUSIONS: Radiosurgery is an effective treatment modality for trigeminal neuralgia. Post treatment numbness is associated with good treatment response and higher integrated dose predicts poor outcome after radiosurgery for trigeminal neuralgia.
Authors: Jeroen B Verheul; Patrick E J Hanssens; Suan Te Lie; Sieger Leenstra; Hendrik Piersma; Guus N Beute Journal: J Neurosurg Date: 2010-12 Impact factor: 5.115
Authors: J C Flickinger; B E Pollock; D Kondziolka; L K Phuong; R L Foote; S L Stafford; L D Lunsford Journal: Int J Radiat Oncol Biol Phys Date: 2001-10-01 Impact factor: 7.038
Authors: Nicolas Massager; José Lorenzoni; Daniel Devriendt; Françoise Desmedt; Jacques Brotchi; Marc Levivier Journal: J Neurosurg Date: 2004-04 Impact factor: 5.115
Authors: Ron I Riesenburger; Steven W Hwang; Clemens M Schirmer; Vasilios Zerris; Julian K Wu; Kerry Mahn; Paul Klimo; John Mignano; Clinton J Thompson; Kevin C Yao Journal: J Neurosurg Date: 2010-04 Impact factor: 5.115
Authors: Douglas Kondziolka; Oscar Zorro; Javier Lobato-Polo; Hideyuki Kano; Thomas J Flannery; John C Flickinger; L Dade Lunsford Journal: J Neurosurg Date: 2010-04 Impact factor: 5.115
Authors: Mohamed H Khattab; Alexander D Sherry; Ellen Kim; Joshua Anderson; Guozhen Luo; Hong Yu; Dario J Englot; Lola B Chambless; Anthony J Cmelak; Albert Attia Journal: J Radiosurg SBRT Date: 2020